DMG-PEG(2000) (solution)

NEU

Artikelnummer	Größe	Manual	Lieferzeit	Preis
Cay42746-500	500 µl	-	6 - 10 Werktage*	35,00 €
Cay42746-1	1 ml	-	6 - 10 Werktage*	55,00 €
Cay42746-2.5	1 each (2.5 mL)	-	6 - 10 Werktage*	90,00 €

Bei Fragen nutzen Sie gerne unser Kontaktformular.
Bestellen Sie auch per E-Mail: info@biomol.com
Größere Menge gewünscht? Bulk-Anfrage

DMG-PEG(2000) is a lipid excipient that has been used in combination with other lipids in the... mehr

Menü schließen

Produktinformationen "DMG-PEG(2000) (solution)"

DMG-PEG(2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles. Administration of fumarylacetoacetate hydrolase (FAH) mRNA in DMG-PEG(2000)-containing lipid nanoparticles increases survival in a mouse model of hereditary tyrosinemia type 1 (HT-1). Formulations containing DMG-PEG(2000) have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines.

Schlagworte:	1,2-Dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000, a-[2,3-bis[(1-oxotetradecyl)oxy]propyl]-?-methoxy-poly(oxy-1,2-ethanediyl)
Hersteller:	Cayman Chemical
Hersteller-Nr:	42746

Eigenschaften

Anwendung:	Lipid excipient, lipid nanoparticle formation
Formel:	(C2H4O)nC32H62O5
Reinheit:	>90%
Format:	Solution

Datenbank Information

CAS :

160743-62-4| Passende Produkte

Handhabung & Sicherheit

Lagerung:	-20°C
Versand:	-20°C (International: -20°C)
Signalwort:	Danger
GHS-Piktogramme:
H-Sätze:	H225, H319, H333
P-Sätze:	P210, P233, P240, P241, P242, P243, P264, P280, P303+361+353, P304+312, P305+351+338, P337+313, P370+378, P403+235, P501